Sort
64,565 grants matching “drug discovery”
An integrated translational approach to overcome drug resistance
$1,239,225Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2019 · CA
CCR Office of Training and Education
$1,239,042Thomas A Misteli · Division Of Basic Sciences - Nci · ZIJ · FY2023 · CA
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,238,889Claire F Verschraegen · Ohio State University · UG1 · FY2021 · CA
NIMH TOXICOLOGICAL EVALUATIONS OF NOVEL LIGANDS
$1,238,808Hannah Ng · Sri International · N01 · FY2010 · MH
Medical Scientist Training Program
$1,238,676Christopher S. Williams · Vanderbilt University · T32 · FY2017 · GM
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)
$1,238,576Michael Benatar · University Of Miami School Of Medicine · U54 · FY2018 · NS
Discovery, characterization and preclinical development of pro-neurogenic drugs
$1,238,447Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2012 · MH
Systems Biology of Tumor Progression and Drug Resistance
$1,238,106Andrea Califano · Columbia University Health Sciences · U01 · FY2016 · CA
Establishing a Gram-Negative Permeation Rule Set Leveraging a Unique Small Molecule Library
$1,237,778Steven Armen Boyd · Venatorx Pharmaceuticals, Inc. · R01 · FY2019 · AI
Kinetic Biomarker for CLL Prognosis
$1,237,577Kinemed, Inc. · R44 · FY2004 · CA
Preclinical Development of HIV-1 Vif Antagonists
$1,237,491Mario Stevenson · University Of Miami School Of Medicine · P01 · FY2014 · MH
A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies
$1,237,360Ryan Gessner · Sonovol, Inc. · R44 · FY2021 · CA
THE PET RADIOTRACER TRANSLATION AND RESOURCE CENTER (PET-RTRC)
$1,237,294Robert J Gropler · Washington University · P41 · FY2019 · EB
Expeditions: Collaborative Research: Understanding the World Through Code
$1,237,220Christopher M Jermaine · William Marsh Rice University · · FY2020 · CSE
Discovery of non-addictive KOR antagonists for migraine prophylaxis
$1,236,992Lori Jean Van Orden · Blackthorn Therapeutics, Inc. · UH3 · FY2017 · NS
Novel SCD1 inhibitors for treatment of cancer
$1,236,819John A Copland · Modulation Therapeutics, Inc. · R42 · FY2019 · CA
Small Molecule Therapeutics for Botullinum Neurotoxin A
$1,236,662Tobin J Dickerson · Scripps Research Institute, The · U01 · FY2009 · AI
SBIR Phase II: An advanced web portal for artificial intelligence (AI)-based comprehensive discovery of repositioning drugs
$1,236,522Qing Ye · Sostos Llc · · FY2025 · TIP
CONTROLLED RELEASE POLYMERS FOR BRAIN TUMORS (U19 CA 528
$1,236,519Johns Hopkins University · U19 · FY2002 · CA
Tau Protein Aggregation Inhibitors for Tauopathies
$1,236,507Qubai Hu · Proteotech, Inc. · R44 · FY2014 · AG
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,236,369Brian J Druker · Oregon Health & Science University · U01 · FY2019 · CA
Stem cells for therapeutics discovery in genetic blood disorders
$1,235,586George Q Daley · Boston Children'S Hospital · U01 · FY2020 · HL
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)
$1,235,166Michael Benatar · University Of Miami School Of Medicine · U54 · FY2014 · NS
Development of ureadepsipetides for drug-resistant infections
$1,235,145Michael Lafleur · Arietis · R01 · FY2020 · AI
Functional genomics and DEC-Tec to identify germ cell-specific contraceptives
$1,234,662Martin M Matzuk · Baylor College Of Medicine · P01 · FY2019 · HD